| Eliza N Sangmuah, MD | |
|
101 E Matthews Street, Suite 200, Matthews, NC 28105-5373 | |
| (704) 246-3936 | |
| (704) 771-1931 |
| Full Name | Eliza N Sangmuah |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 28 Years |
| Location | 101 E Matthews Street, Matthews, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215931894 | NPI | - | NPPES |
| 5902523 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 200501665 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Medical Center | Rock hill, SC | Hospital |
| Novant Health Matthews Medical Center | Matthews, NC | Hospital |
| J Arthur Dosher Memorial Hospital | Southport, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Matthews Internal Medicine Pllc | 8729273180 | 3 |
| Southeastern Hospitalist Services Pc | 3476855420 | 276 |
News Archive
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.
Inhibitex, Inc. today reported that the U.S. Food and Drug Administration ("FDA") has designated the investigation of INX-08189, a potent guanosine nucleotide polymerase inhibitor for the treatment of chronic hepatitis C viral infection, as a Fast Track development program.
The Rockefeller University and the Stavros Niarchos Foundation today announced a $3 million expansion of their longstanding partnership for research and medicine, bolstering Rockefeller's round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.
New diagnostic tests for auditory processing disorder (APD), which is estimated to affect between 2 and 7 percent of children could be available within five years through research funded by the charity Action on Hearing Loss. The news is announced in the charity's latest Hearing Progress report.
A mutant rat that mimics a 400-pound human is helping scientists understand early vascular changes that make walking a pain for more than 2 million Americans.
› Verified 8 days ago
| Entity Name | Cumberland County Hospital System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881946242 PECOS PAC ID: 1850204041 Enrollment ID: O20031112000693 |
News Archive
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.
Inhibitex, Inc. today reported that the U.S. Food and Drug Administration ("FDA") has designated the investigation of INX-08189, a potent guanosine nucleotide polymerase inhibitor for the treatment of chronic hepatitis C viral infection, as a Fast Track development program.
The Rockefeller University and the Stavros Niarchos Foundation today announced a $3 million expansion of their longstanding partnership for research and medicine, bolstering Rockefeller's round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.
New diagnostic tests for auditory processing disorder (APD), which is estimated to affect between 2 and 7 percent of children could be available within five years through research funded by the charity Action on Hearing Loss. The news is announced in the charity's latest Hearing Progress report.
A mutant rat that mimics a 400-pound human is helping scientists understand early vascular changes that make walking a pain for more than 2 million Americans.
› Verified 8 days ago
| Entity Name | Bladen Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558537282 PECOS PAC ID: 6800967969 Enrollment ID: O20080617000314 |
News Archive
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.
Inhibitex, Inc. today reported that the U.S. Food and Drug Administration ("FDA") has designated the investigation of INX-08189, a potent guanosine nucleotide polymerase inhibitor for the treatment of chronic hepatitis C viral infection, as a Fast Track development program.
The Rockefeller University and the Stavros Niarchos Foundation today announced a $3 million expansion of their longstanding partnership for research and medicine, bolstering Rockefeller's round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.
New diagnostic tests for auditory processing disorder (APD), which is estimated to affect between 2 and 7 percent of children could be available within five years through research funded by the charity Action on Hearing Loss. The news is announced in the charity's latest Hearing Progress report.
A mutant rat that mimics a 400-pound human is helping scientists understand early vascular changes that make walking a pain for more than 2 million Americans.
› Verified 8 days ago
| Entity Name | Matthews Internal Medicine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528376712 PECOS PAC ID: 8729273180 Enrollment ID: O20101110001218 |
News Archive
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.
Inhibitex, Inc. today reported that the U.S. Food and Drug Administration ("FDA") has designated the investigation of INX-08189, a potent guanosine nucleotide polymerase inhibitor for the treatment of chronic hepatitis C viral infection, as a Fast Track development program.
The Rockefeller University and the Stavros Niarchos Foundation today announced a $3 million expansion of their longstanding partnership for research and medicine, bolstering Rockefeller's round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.
New diagnostic tests for auditory processing disorder (APD), which is estimated to affect between 2 and 7 percent of children could be available within five years through research funded by the charity Action on Hearing Loss. The news is announced in the charity's latest Hearing Progress report.
A mutant rat that mimics a 400-pound human is helping scientists understand early vascular changes that make walking a pain for more than 2 million Americans.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eliza N Sangmuah, MD 101 E Matthews Street, Suite 200, Matthews, NC 28105-5373 Ph: (704) 246-3936 | Eliza N Sangmuah, MD 101 E Matthews Street, Suite 200, Matthews, NC 28105-5373 Ph: (704) 246-3936 |
News Archive
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.
Inhibitex, Inc. today reported that the U.S. Food and Drug Administration ("FDA") has designated the investigation of INX-08189, a potent guanosine nucleotide polymerase inhibitor for the treatment of chronic hepatitis C viral infection, as a Fast Track development program.
The Rockefeller University and the Stavros Niarchos Foundation today announced a $3 million expansion of their longstanding partnership for research and medicine, bolstering Rockefeller's round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.
New diagnostic tests for auditory processing disorder (APD), which is estimated to affect between 2 and 7 percent of children could be available within five years through research funded by the charity Action on Hearing Loss. The news is announced in the charity's latest Hearing Progress report.
A mutant rat that mimics a 400-pound human is helping scientists understand early vascular changes that make walking a pain for more than 2 million Americans.
› Verified 8 days ago
Vidyasagargoud Marupakula, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Healing Way, Matthews, NC 28104 Phone: 980-993-2240 | |
Zelalem Atakilt Gebreananya, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-9740 Fax: 704-384-9565 | |
Nusrat Ahmad Chaudhary, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-841-8151 | |
Dr. Henry D Cremisi, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-5416 Fax: 704-384-5992 | |
Dr. Kevin M. Rudisel, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-5420 Fax: 704-384-5424 | |
Dr. Abdul Karim Garuba, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9705 Northeast Pkwy Ste 400, Matthews, NC 28105 Phone: 704-844-8971 Fax: 704-844-8972 | |
Dr. Keithe Saclayan Shensky, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-841-8151 Fax: 704-841-9228 |